Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Director departure
Letter to company
Asset disposition
Appointed director
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/03/2023 SC 13G/A Bain Irwin Allen reports a 4.7% stake in Navidea Biopharmaceuticals, Inc.
06/30/2023 SC 13G/A Bain Irwin Allen reports a 4.7% stake in Navidea Biopharmaceuticals, Inc.
02/19/2013 SC 13G/A Platinum-Montaur Life Sciences, LLC reports a 10% stake in Navidea Biopharmaceuticals, Inc.
02/22/2011 SC 13G/A NEOPROBE CORP reports a 9.9% stake in Neoprobe Corporation
02/26/2010 SC 13G/A NEOPROBE CORP reports a 9.2% stake in Neoprobe Corporation
02/12/2004 SC 13G/A ARIES FINANCIAL SERVICES INC reports a 2.3% stake in Neprobe Corporation.
02/19/2003 SC 13G/A ARIES FINANCIAL SERVICES INC reports a 12.2% stake in Neoprobe Corp..
02/11/1999 SC 13G/A SCUDDER KEMPER INVESTMENTS INC has filed a Schedule 13D for Neoprobe Corp
02/12/1998 SC 13G/A TCW GROUP INC reports a 1.6% stake in Neoprobe Corp.
09/28/1995 SC 13G/A LEHMAN BROTHERS HOLDINGS INC reports a 4.2% stake in Neoprobe Corporation
09/28/1995 SC 13G/A LEHMAN BROTHERS HOLDINGS INC reports a 7.1% stake in Neoprobe Corporation

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy